Group 2 vaccinia virus, Brazil.
Subject: Smallpox
Dairy cattle
Vaccinia
Authors: Assis, Felipe Lopes
Borges, Lara Apolinario
Ferreira, Paulo Cesar Peregrino
Bonjardim, Claudio Antonio
Trindade, Giliane de Souza
Lobato, Zelia Ines Portela
Guedes, Maria Isabel Maldonado
Mesquita, Vaz
Kroon, Erna Geessien
Abrahao, Jonatas Santos
Pub Date: 12/01/2012
Publication: Name: Emerging Infectious Diseases Publisher: U.S. National Center for Infectious Diseases Audience: Academic; Professional Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2012 U.S. National Center for Infectious Diseases ISSN: 1080-6040
Issue: Date: Dec, 2012 Source Volume: 18 Source Issue: 12
Product: Product Code: 0240100 Dairy Cattle; 0240110 Dairy Cows NAICS Code: 11212 Dairy Cattle and Milk Production SIC Code: 0241 Dairy farms
Accession Number: 313345657
Full Text: Throughout most of Brazil, vaccinia virus (VACV), family Poxviridae, is the etiologic agent of bovine vaccinia (7). Outbreaks often occur on unhygienic rural properties and cause mild to severe rashes on teats and udders of dairy cows and various locations on humans (7,2). Dairy workers usually seek medical care for the painful lesions, but rarely are they hospitalized. Some studies suggest an association between these outbreaks of bovine vaccinia and the VACV strains used during the World Health Organization smallpox eradication campaign (3). Since 1999, VACV strains in Brazil have been investigated (2-8); biological and molecular approaches indicated 2 distinct groups of these viruses (9,70). In 2011, a bovine vaccinia outbreak occurred in Serro County, Minas Gerais state, in southeastern Brazil, one of the largest milk-producing regions in Brazil. The outbreak affected 91 dairy cows and 3 dairy workers, 1 of whom was hospitalized (online Technical Appendix Figure 1, panel A, wwwnc.cdc.gov/EID/pdfs/12-0145.pdf). Our aim was to elucidate the genetic and phenotypic characteristics of this VACV isolate.

The Study

The outbreak affected 2 farms, 91 cows, and 3 humans (Figure 1). On day 1, on farm 1, the index case was a sick cow with ulcerative lesions on the teats and udder. On day 3, the owner of farm 1 (patient A), who had had direct contact with the sick cow, noticed lesions on his hand. On day 5, another 6 cows on farm 1 became sick, and patient A went to farm 2 and handled healthy cattle. On day 7, all 14 cows on farm 1 were sick. On day 9, some cows on farm 2 became sick. On day 12, the owner of farm 2 (patient B) and his employee (patient C) became sick. On day 15, patient C was hospitalized with high fever, lymphadenopathy, prostration, and painful vesicular-pustular lesions on his hands and arms. He received clinical support and remained hospitalized for 10 days. He had no immunologic disorders and took no medications that could be associated with his severe clinical condition. According our investigation, only those 3 patients had direct contact with the infected cattle during the outbreak.

By day 18, all 77 cows on farm 2 were sick. On day 24, veterinary surveillance teams isolated these farms for 8 days. On day 26, patient C returned to work although lesions remained on his hands and arms (online Technical Appendix Figure 1, panel B). By day 28, all cattle were recovering.

To identify the etiologic agent responsible for the outbreak, on day 27 we collected swab samples from lesions of patients B and C (not from patient A, whose lesions were healing) and from 1 infected cow (from farm 2). Samples were placed in Vero cells for virus isolation as described (2) and then purified in a sucrose gradient (77). The isolates from the patients B and C and the cow were named VACV Serro human 1/2011 (SH1V/2011), VACV Serro human 2/2011 (SH2V/2011), and VACV Serro bovine 1/2011 (SB1V/2011), respectively.

The isolates were examined by PCR for the A56R gene (hemagglutinin [HA]), and the fragments obtained (950 bp) were sequenced and analyzed as described (2,72,73). The nucleotide sequences showed 100% identity among all VACV Serro 2011 isolates and exhibited high identity with VACV strains from Brazil, particularly SPAn232 (99.8% identity) and GuaraniP1 (99.5% identity) viruses. The HA phylogenetic tree clustered most VACV isolates from Brazil together, mainly because of the presence of the deletion signature (group 1). However, VACV Serro 2011 isolates did not exhibit this signature and instead clustered with VACV strains that are less frequently isolated during outbreaks in Brazil (group 2) (Figure 2, panel A).

[FIGURE 1 OMITTED]

To further characterize the virus, we also sequenced the A26L gene (ati) (74). Because HA sequences were identical for SH1V/2011, SH2V/2011, and SB1V/2011 (and hypothetically represent the same isolate), we selected SH2V/2011 to analyze for ati and virulence in BALB/c mice. The ati gene is highly polymorphic in VACV strains from Brazil, and some strains exhibit a large deletion in the ati gene (75). Therefore, we used ati to character ize the VACV strains from Brazil. A 1,600-bp fragment that also did not contain the deletion was amplified from SH2V/2011. This virus exhibits no deletion in either the HA or ati genes in the analyzed regions of these genes. The ati phylogenetic tree (Figure 2, panel B) showed that SH2V/2011 also clustered with SPAn232 virus (group 2) and was segregated from the other group 1 VACV strains.

Given the atypical genetic profile of SH2V/2011 and the long-term hospitalization of patient C, we investigated the virulence of this isolate in mice (following the rules of Committee of Ethics for Animal Experimentation, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil). A total of 16 BALB/c mice were divided into 4 groups of 4 mice each. We intranasally inoculated 4 mice with 10-mL doses of viral suspensions containing 106 PFUs, as described (70). Two groups were inoculated with VAVC-GuaraniP1 and VACV-GuaraniP2 as virulent and nonvirulent controls, respectively. Another group was inoculated with phosphate-buffered saline. The SH2V/2011 sample was highly virulent in BALB/c mice; morbidity rate was high (online Technical Appendix Figure 2), thereby supporting the grouping of this sample in the virulent cluster. The animals that were infected with SH2V/2011 exhibited ruffled fur, arched backs, and weight loss, much like those infected with VACV-GuaraniP1. No clinical signs were observed in mice that had been inoculated with either VACV-GuaraniP2 or phosphate-buffered saline.

[FIGURE 2 OMITTED]

To further characterize the virus, we also performed a plaque phenotype assay in BSC-40 cell cultures. The VACV strains from Brazil that exhibited virulence in a BALB/c model usually formed large plaques in BSC-40 cell cultures. This assay showed that, in contrast to VACV-GuaraniP2, in BSC-40 cell cultures, SH2V/2011 induces the formation of large plaques that are similar to those induced by VACV-Western Reserve and VACV-GuaraniP1 (online Technical Appendix Figure 3).

Conclusions

Our results indicate that VACV Serro-2011 is a new mouse-virulent VACV strain associated with an outbreak that affected cows and humans. Recently, several VACV strains have been isolated in Brazil, most exhibiting a signature deletion in A56R, few or no deletions in the ati gene, and low virulence in mouse models. In contrast, the VACV isolated from the outbreak reported here, affecting cattle and humans, exhibited virulence in mice but no deletions in either the A56R or ati genes. This strain is genetically and phenotypically distinct from the Serro-2 strain that was isolated from the same region in 2005 (7); thus, >1 VACV might be circulating in Serro and possibly other regions of Brazil (7,8).

During outbreaks of bovine vaccinia, hospitalization of humans, especially for several days, is unusual. Unfortunately, despite the development of in vivo models for study and differentiation of VACV from Brazil, no clear association between viral genetics and disease severity in humans and cattle has been shown. Although preliminary, the data presented here indicate a possible association between these 2 factors, considering the hospitalization of patient C to be long term. Although the surveillance and characterization of VACV have advanced in recent years, observation and description of any clinical characteristics of infected humans and cattle are still helpful. Such observations might be associated with genotypic and phenotypic features of VACV, which could influence surveillance and control strategies for the management of VACV outbreaks.

Acknowledgments

We thank our colleagues from the Laboratorio de Virus for their excellent technical support.

Financial support was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, and Ministerio da Agricultura, Pecuaria e Abastecimento. F.L.A.received fellowship funding from CNPq; I.A.B. received fellowship funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; and E.G.K., C.A.B., G.T., and P.C.P.F. are researchers from CNPq.

Mr Assis is a biologist and doctoral candidate at the Laboratorio de Virus, Microbiology Department, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais. His research interests focus on monitoring, phylogeny, and preventing emerging infectious diseases.

Author affiliation: Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

DOI: 10.3201/eid1812.120145

References

(1.) Damon IK. Poxviruses. In: Knipe DM, Howley PM, editors. Fields virology, 5th ed., vol. II. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 2947.

(2.) Abrahao JS, Guedes MI, Trindade GS, Fonseca FG, Campos RK, Mota BF, et al. One more piece in the VACV ecological puzzle: could peridomestic rodents be the link between wildlife and bovine vaccinia outbreaks in Brazil? PLoS ONE. 2009;4:e7428. http:// dx.doi.org/10.1371/journal.pone.0007428

(3.) Damaso CR, Esposito JJ, Condit RC, Moussatche N. An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine. Virology. 2000;277:439-49. http://dx.doi.org/10.1006/viro.2000.0603

(4.) Fonseca FG, Lanna MC, Campos MAS, Kitajima EW, Peres JN, Golgher RR, et al. Morphological and molecular characterization of the poxvirus BeAn 58058. Arch Virol. 1998;143:1171-86. http:// dx.doi.org/10.1007/s007050050365

(5.) da Fonseca FG, Trindade GS, Silva RL, Bonjardim CA, Ferreira PC, Kroon EG. Characterization of a vaccinia-like virus isolated in a Brazilian forest. J Gen Virol. 2002;83:223-8.

(6.) Trindade GS, Lobato ZIP, Drumond BP, Leite JA, Trigueiro RC, Guedes MI, et al. Isolation of two vaccinia virus strains from a single bovine vaccinia outbreak in rural area from Brazil: implications on the emergence of zoonotic orthopoxviruses. Am J Trop Med Hyg. 2006;75:486-90.

(7.) Trindade GS, Guedes MI, Drumond BP, Mota BE, Abrahao JS, Lobato ZI, et al. Zoonotic vaccinia virus: clinical and immunological characteristics in a naturally infected patient. Clin Infect Dis. 2009;48:e37-40. http://dx.doi.org/10.1086/595856

(8.) Campos RK, Brum MC, Nogueira CE, Drumond BP, Alves PA, Lima LS, et al. Assessing the variability of Brazilian vaccinia virus isolates from a horse exanthematic lesion: coinfection with distinct viruses. Arch Virol. 2011;156:275-83. http://dx.doi.org/10.1007/ s00705-010-0857-z

(9.) Trindade GS, Emerson GL, Carroll DS, Kroon EG, Damon IK. Brazilian vaccinia viruses and their origins. Emerg Infect Dis. 2007;13:965-72. http://dx.doi.org/10.3201/eid1307.061404

(10.) Ferreira JM, Drumond BP, Guedes MI, Xavier MA, Leite CM, Arantes RM, et al. Virulence in murine model shows the existence of two distinct populations of Brazilian vaccinia virus strains. PLoS One;2008;3:1-10.

(11.) Joklik WK. The purification of four strains of poxvirus. Virology. 1962;18:9-18. http://dx.doi.org/10.1016/0042-6822(62)90172-1

(12.) Sambrook E, Fritsch F, Maniatis T. Molecular cloning. Cold Spring Harbor (NY): Cold Spring Harbor Press; 1989.

(13.) Ropp SL, Jin Q, Knight JC, Massung RF, Esposito JJ. PCR strategy for identification and differentiation of smallpox and other orthopox viruses. J Clin Microbiol. 1995;33:2069-76.

(14.) Meyer H, Ropp SL, Esposito JJ. Gene for A-type inclusion body protein is useful for a polymerase chain reaction assay to differentiate orthopoxviruses. J Virol Methods. 1997;64:217-21. http:// dx.doi.org/10.1016/S0166-0934(96)02155-6

(15.) Leite JA, Drumond BP, Trindade GS, Bonjardim CA, Ferreira PC, Kroon EG. Brazilian vaccinia virus strains show genetic polymorphism at the ati gene. Virus Genes. 2007;35:531-9. http://dx.doi. org/10.1007/s11262-007-0133-9

Address for correspondence: Jonatas Santos Abrahao, Universidade Federal de Minas Gerais-Microbiology, Av. Antonio Carlos, 6627 Belo Horizonte, Minas Gerais 31270-901, Brazil; email: jonatas.abrahao@ gmail.com
Gale Copyright: Copyright 2012 Gale, Cengage Learning. All rights reserved.